References
- Aitio A., Vainio H. Acta Pharmac. Tox. 1976; 39: 555
- Bradbury S. L., Clark J. F., Steinman C. R., Jakoby W. B. Methods Enz. 1975; 41: 354, (Part B)
- Canady W. J., Robinson D. A., Colby H. D. Biochem. Pharmac. 1974; 23: 3075
- Cantrell E. T., Abreu-Greenberg M. Life Sci. 1975; 17: 317
- Carlone M. F., Fouts J. R. Xenobiotica 1974; 4: 705
- Dean B. J. Mutation Res. 1978; 47: 75
- Harper C., Drew R. T., Fouts J. R. Biological Reactive Intermediates, D. J. Jollow, J. J. Kocsis, R. Snyder, H. Vainio. Plenum Press, London 1975; 302–311
- Juntunen J., Teträväinen H., Eriksson K., Panula P., Larsen A. Acta neuropath. (Berl.) 1978; 41: 131
- Laham S. Industr. Med. 1970; 39: 61
- Mezey E. Biochem. Pharmac. 1976; 25: 869
- National Institute For Occupational Safety and Health. Criteria for a Recommended Standard… Occupational Exposure to Xylene. U.S. Department of Health, Education and Welfare. 1975, (Washington, D.C. 20402: U.S. Government Printing Office)
- Patel J. M., Harper C., Drew R. T. Drug Metab. Disp. 1978; 6: 368
- Prough R. A., Burke M. D., Mayer R. T. Methods Enz. 1978; 52: 372, (Part C)
- Rubin E., Lieber C. S. Science, N.Y. 1968; 162: 690
- Saville B. Analyst 1958; 83: 670
- Savolainen H., Vainio H., Helojoki M., Elovaara E. Arch. Tox. 1978; 41: 195
- Schenkman J. B., Remmer H., Estabrook R. W. Molec. Pharmac. 1967a; 3: 113
- Schenkman J. B., Remmer H., Estabrook R. W. Molec. Pharmac. 1967b; 3: 516
- Sedivec V., Flek J. Int. Arch. Occup. Envir. Hlth. 1976; 37: 205
- Thurman R. G., McKenna W. R., Brentzel H. J., Jr., Hesse S. Fedn. Proc. 1975; 34: 2075
- Vainio H., Elovaara E. Biochem. Pharmac. 1979; 28: 2001